Author

Teofilia Acheampong

Observed name: Acheampong, Teofilia

Institution: Bristol-Myers Squibb (United States)

Observed institutions: University of California, Irvine, Bristol-Myers Squibb (United States), Columbia University

ORCID: 0000-0003-4752-0081

Observed ORCID: 0000-0003-4752-0081

OpenAlex ID: A5068518677

Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016

2020 · Teofilia Acheampong, Rebecca D. Kehm, et al. · JAMA Network Open · 172

PDF

Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study

2020 · Teofilia Acheampong, Luohua Jiang, et al. · Scientific Reports · 24

PDF

Occupational exposure to endocrine disrupting substances and the risk of breast Cancer: the Singapore Chinese health study

2018 · Teofilia Acheampong, Jian-Min Yuan, et al. · BMC Public Health · 14

PDF

Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density

2020 · Erica J. Lee Argov, Teofilia Acheampong, et al. · Breast Cancer Research · 13

PDF

Treatment Patterns and Costs Among US Patients With Diffuse Large B-Cell Lymphoma not Treated With 2L Stem Cell Transplantation

2024 · Teofilia Acheampong, Tao Gu, et al. · Future Oncology · 4

Clinical Outcomes in Real-World Patients (RW) with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): A Retrospective Study Using Electronic Health Records from Flatiron Health and COTA Vantage Databases

2023 · Hans C. Lee, Sundar Jagannath, et al. · Blood · 1

Journey of Relapsed or Refractory Multiple Myeloma (RRMM) after Quadruple-Class Exposure (QCEx): Poor Outcomes and High Attrition

2026 · Doris K. Hansen, Lin Wang, et al. · Transplantation and Cellular Therapy

Journey of relapsed or refractory multiple myeloma (RRMM) after quadruple-class exposure (QCEx): Poor outcomes and high attrition

2025 · Doris Hansen, Lin Wang, et al. · Blood

PDF

Treatment Patterns and Outcomes in Quad-Class Exposed (QCE) Relapsed Refractory Multiple Myeloma (RRMM): Investigating Critical Unmet Needs

2025 · Doris Hansen, Lin Wang, et al. · Clinical Lymphoma Myeloma & Leukemia

Real-World (RW) Treatment (Tx) Patterns and Outcomes in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) Previously Treated with Lenalidomide and an Anti-CD38 Monoclonal Antibody: Data from the Japan Medical Data Vision Database

2024 · Junya Kuroda, Teofilia Acheampong, et al. · Blood

PDF

P-044 External Control Analysis for KarMMa-3: Idecabtagene Vicleucel (ide-cel) vs Real-World Standard of Care (RW SoC; COTA) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

2024 · Hans Lee, Kevin Towle, et al. · Clinical Lymphoma Myeloma & Leukemia

Scientific uncertainty and perceived mammography benefits in women screened for breast cancer

2023 · Teofilia Acheampong, Carmen B. Rodríguez, et al. · Cancer Causes & Control

Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use

2022 · Teofilia Acheampong, Erica J. Lee Argov, et al. · Cancer Causes & Control

Abstract A54: Multisystemic biologic risk index and cancer mortality: Differences by age group and race/ethnicity

2018 · Teofilia Acheampong, Andrew Odegaard · Cancer Epidemiology Biomarkers & Prevention

Multi-Systemic Biological Risk and its Association with Discrimination, Cancer Mortality, and All-Cause Mortality

2018 · Teofilia Acheampong · eScholarship (California Digital Library)

PDF

Abstract 2599: Association of periodontal disease and breast health in women undergoing screening mammography

2016 · Hannah Lui Park, Teofilia Acheampong, et al. · Cancer Research

Works count: 19

Citation count: 228

H-index: 4

I10-index: 4